Weerasinghe Rohan 4

What Happened
Rohan Weerasinghe, a director of PHINIA Inc. (PHIN), received equity awards on May 22, 2026. The filing shows two award-type (A) acquisitions: 3,075 deferred restricted stock units (DRSUs) valued at $74.80 each (total value $230,010) and an additional 2,140 derivative units recorded at $0. Both entries are derivative awards (not open-market purchases or sales).

Key Details

• Transaction date: 2026-05-22; filing date: 2026-05-27 (appears to be filed after the transaction date).
• Awards shown:
  • 3,075 DRSUs @ $74.80 — aggregate value $230,010 (derivative award).
  • 2,140 units @ $0 — recorded as derivative award/units.
• Shares owned after the transaction: not specified in the provided excerpt.
• Footnotes of note:
  • F1: Filing includes 8,551 DRSUs that have already vested and will settle into shares upon the reporting person’s termination of board service.
  • F2/F3: The 3,075 and 2,140 DRSUs were elected in lieu of the annual restricted stock grant and cash retainer; each DRSU is economically equivalent to one share, vests May 22, 2027, and will settle into common stock (including dividend equivalents) upon termination of board service under the Director Deferred Compensation Program and 2023 Stock Incentive Plan.
• Transaction code: A = Award/Grant (derivative).

Context
DRSUs are deferred-compensation awards that convert into shares later (here, vesting and/or settlement tied to termination of board service), so these grants do not represent an immediate market purchase or sale. Such awards are common as director compensation and are not direct signals of an insider buying or selling stock. The filing date is several days after the transaction date, which may indicate a late Form 4 filing.